Tempus AI vs 10X Genomics Inc — how do they compare? Tempus AI trades at $49 (market cap $8.69B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Tempus AI is the larger of the two by market cap, and 10X Genomics Inc is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.
| TEM | TXG | |
|---|---|---|
Market Cap | $8.69B | $5.48B |
Sector | Broad Market / Factor | Health |
52-Week High | $103.25 | $45.80 |
52-Week Low | $42.37 | $11.34 |
Enterprise Value | $9.37B | $5.02B |
Trailing returns across standard periods
Latest headlines on both assets
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →